Compare VSTM & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSTM | RERE |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 723.8M | 859.3M |
| IPO Year | 2012 | 2021 |
| Metric | VSTM | RERE |
|---|---|---|
| Price | $6.16 | $6.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $13.38 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 1.5M |
| Earning Date | 03-19-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $13,379,000.00 | ★ $2,759,212,837.00 |
| Revenue This Year | $208.54 | $30.64 |
| Revenue Next Year | $251.40 | $24.84 |
| P/E Ratio | ★ N/A | $35.36 |
| Revenue Growth | ★ 33.79 | 27.95 |
| 52 Week Low | $4.01 | $2.00 |
| 52 Week High | $11.25 | $6.47 |
| Indicator | VSTM | RERE |
|---|---|---|
| Relative Strength Index (RSI) | 35.18 | 62.72 |
| Support Level | $6.14 | $5.73 |
| Resistance Level | $6.53 | $5.95 |
| Average True Range (ATR) | 0.48 | 0.26 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 3.12 | 58.62 |
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.